Personality and Mental Health is a leading academic journal published by WILEY that focuses on the intricate relationships between personality traits and various mental health outcomes. Established in 2009, this journal has become a vital resource for researchers, practitioners, and students in the fields of psychiatry, health policy, and mental health. With its Q1 rank in Health Policy and Q2 rank in Psychiatry and Mental Health, it symbolizes a commitment to high-impact research, evidenced by its strong Scopus rankings, including a remarkable 11th place in Nursing - Psychiatric Mental Health. The journal offers insights into the latest trends and interventions that affect mental well-being, thereby influencing policy and practice. Although not an open-access title, it remains a crucial reference point for those invested in the mental health sector and is dedicated to advancing understanding and treatment of personality-related mental health issues through a multidisciplinary approach, making it an essential addition to any academic library.

Clinical Psychologist, an esteemed journal published by TAYLOR & FRANCIS LTD, has been at the forefront of advancing the field of clinical psychology since its inception in 1996. With a dedicated focus on empirical research, theoretical discussions, and practical applications, this journal aims to bridge the gap between science and practice in psychology. Holding a notable impact factor and currently ranked in the Q3 quartile for 2023 in Clinical Psychology, it serves as a vital resource for researchers, professionals, and students alike, fostering the exchange of knowledge and innovative ideas. While the journal does not offer open access, its reputable publisher ensures a rigorous peer-review process, elevating the quality and relevance of each published article. Through its comprehensive scope, Clinical Psychologist remains committed to addressing pressing issues in mental health, making it an essential platform for the ongoing development and dissemination of psychological science.

JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT is a prominent scholarly publication dedicated to advancing the field of clinical psychology through innovative research and comprehensive assessments of psychological disorders. Published by Springer/Plenum Publishers in the United States, this journal has an established history of contributing to the academic community since its inception in 1985, continuing its mission until 2024. With an impact factor that properly reflects its academic rigor and relevance, it ranks in the Q2 category in Clinical Psychology for 2023, placing it within the top tier of academic journals in the field. Researchers, professionals, and students can expect to find a wealth of insightful articles that delve into the complexities of psychopathology and behavioral assessment, fostering a deeper understanding of mental health issues. Although open access options are not available at this time, subscribers and institutions have the privilege of accessing critical findings that could transform clinical practices and inform future research initiatives.

Journal of Psychopathology, published by PACINI EDITORE, is a pivotal academic resource in the realms of clinical psychology and psychiatry. With an ISSN of 1592-1107 for print and 2499-6904 for electronic formats, this journal has been a significant platform for scholarly discourse since its inception in 2001, continuing through to 2024. Situated in Pisa, Italy, it is recognized for its rigorous academic standards, as evidenced by its Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health categories as of 2023. The journal focuses on publishing high-quality research articles, reviews, and case studies that contribute to a comprehensive understanding of psychopathological issues. Although not open access, the journal promotes accessibility through various institutional subscriptions, ensuring wide dissemination of valuable insights. With significant Scopus rankings—177 out of 311 in Clinical Psychology and 360 out of 567 in Psychiatry and Mental Health—the journal is essential for researchers, practitioners, and students dedicated to advancing knowledge and practices in mental health.

Clinica y Salud is a prominent peer-reviewed journal in the field of Clinical Psychology, published by the COLEGIO OFICIAL PSICOLOGOS MADRID. With a focus on disseminating high-quality research, this journal has been an Open Access publication since 1990, ensuring that its valuable findings are accessible to researchers, practitioners, and students worldwide. Based in Spain, Clinica y Salud not only contributes to the academic community through its rigorous peer-review process but also encourages the practical application of psychological research in clinical settings. As of 2023, the journal holds a commendable Q2 category ranking within Clinical Psychology, reflecting its significant impact with a Scopus rank of 150/311 and a respectable 51st percentile. Covering research from 2013 to 2024, it provides innovative insights and diverse perspectives, making it an essential resource for those engaged in the evolving landscape of psychological health and well-being.

BJPsych Advances is a distinguished journal dedicated to the field of Psychiatry and Mental Health, published by Cambridge University Press. With an ISSN of 2056-4678 and an E-ISSN of 2056-4686, this journal serves as a crucial platform for disseminating high-quality research and advancements in psychiatric science. Holding a position in the Q3 quartile as of 2023, it ranks 330 out of 567 in the Scopus database, representing a significant contribution to the mental health community, with a 41st percentile status. The journal not only covers recent innovations and methodologies but also emphasizes practical applications in clinical settings, making it an essential resource for researchers, practitioners, and students alike. With a commitment to fostering a deeper understanding of psychiatric disorders and their implications, BJPsych Advances plays a vital role in enhancing the standards of mental healthcare across the globe, bridging the gap between academic research and clinical practice.

PSYCHIATRY RESEARCH-NEUROIMAGING, published by Elsevier Ireland Ltd, stands at the intersection of neuroscience, psychiatry, and medical imaging, specializing in the latest advancements in neuroimaging techniques and their applications in psychiatric research. With a robust history since 1990, this esteemed journal features original research, reviews, and case studies that contribute significantly to the understanding of brain function in mental health disorders. Holding a notable Impact Factor and classified in Q2 for the fields of Neuroscience and Psychiatry and Q1 for Radiology, it serves as a vital resource for scholars and practitioners seeking to advance their knowledge in these domains. The journal is indexed in major databases, enhancing visibility and accessibility for global researchers. While it currently does not follow an open-access model, its reputable standing in Scopus ranks, alongside its targeted scope, makes it indispensable for those invested in neuroimaging research and its implications in psychiatry.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

JAMA Psychiatry, published by the American Medical Association, stands as a leading peer-reviewed journal in the fields of psychiatry and mental health, featuring an impressive impact factor that reflects its significance in advancing research and clinical practice. With an ISSN of 2168-622X and an E-ISSN of 2168-6238, this journal operates on a comprehensive access model that allows for the dissemination of vital research findings to a global audience. Since its inception in 2013, JAMA Psychiatry has consistently ranked in the top quartile (Q1) in both the Medicine (miscellaneous) and Psychiatry and Mental Health categories, with a remarkable Scopus rank of #4 out of 567, placing it in the 99th percentile. Addressed from its headquarters in Chicago, Illinois, the journal's objectives encompass the publication of original clinical research, innovative treatment strategies, and insightful reviews that enrich the understanding of psychiatric disorders. By bridging the gap between research and real-world application, JAMA Psychiatry remains an essential resource for researchers, clinicians, and students dedicated to improving mental health outcomes.

NORDIC JOURNAL OF PSYCHIATRY is a pivotal publication in the field of psychiatry and mental health, dedicated to advancing knowledge and fostering dialogue among researchers, clinicians, and students. Published by Taylor & Francis Ltd, this esteemed journal, with an ISSN of 0803-9488 and E-ISSN 1502-4725, serves as a platform for innovative research and critical reviews that address crucial mental health issues affecting Nordic populations and beyond. Its impact is underscored by a notable Q2 ranking in the Psychiatry and Mental Health category for 2023, along with a respectable position within the Scopus ranking at #268 out of 567. The journal has been a reliable source of scientific inquiry since its inception in 1947, and it aims to facilitate significant advancements in the understanding and treatment of psychiatric disorders. By providing access to high-quality research without open access options, NORDIC JOURNAL OF PSYCHIATRY remains a must-read for those dedicated to progressing mental health science in a global context.